- Open Access
Is non-operative management safe and effective for all splenic blunt trauma? A systematic review
Critical Care volume 17, Article number: R185 (2013)
The goal of non-operative management (NOM) for blunt splenic trauma (BST) is to preserve the spleen. The advantages of NOM for minor splenic trauma have been extensively reported, whereas its value for the more severe splenic injuries is still debated. The aim of this systematic review was to evaluate the available published evidence on NOM in patients with splenic trauma and to compare it with the operative management (OM) in terms of mortality, morbidity and duration of hospital stay.
For this systematic review we followed the "Preferred Reporting Items for Systematic Reviews and Meta-analyses" statement. A systematic search was performed on PubMed for studies published from January 2000 to December 2011, without language restrictions, which compared NOM vs. OM for splenic trauma injuries and which at least 10 patients with BST.
We identified 21 non randomized studies: 1 Clinical Controlled Trial and 20 retrospective cohort studies analyzing a total of 16,940 patients with BST. NOM represents the gold standard treatment for minor splenic trauma and is associated with decreased mortality in severe splenic trauma (4.78% vs. 13.5% in NOM and OM, respectively), according to the literature. Of note, in BST treated operatively, concurrent injuries accounted for the higher mortality. In addition, it was not possible to determine post-treatment morbidity in major splenic trauma. The definition of hemodynamic stability varied greatly in the literature depending on the surgeon and the trauma team, representing a further bias. Moreover, data on the remaining analyzed outcomes (hospital stay, number of blood transfusions, abdominal abscesses, overwhelming post-splenectomy infection) were not reported in all included studies or were not comparable, precluding the possibility to perform a meaningful cumulative analysis and comparison.
NOM of BST, preserving the spleen, is the treatment of choice for the American Association for the Surgery of Trauma grades I and II. Conclusions are more difficult to outline for higher grades of splenic injury, because of the substantial heterogeneity of expertise among different hospitals, and potentially inappropriate comparison groups.
Trauma is the fourth cause of death in the overall population and the first one in individuals below the age of 40 in Western countries [1, 2]. Abdominal trauma can be classified as blunt or penetrating according to the agent and its mechanism of action [1–3].
The spleen is the most frequently injured organ in abdominal blunt trauma, mainly because of its highly vascularized parenchyma and its anatomic location. Spleen is the only structure involved in almost 46% of blunt trauma (BT). On the other hand the liver (41.7%), kidneys (16.4%), mesentery (15.1%), small and large bowel (10.1% and 6.3%, respectively), pancreas (5%) and omentum may concur with splenic injuries in the remaning part of BT [1, 2].
Splenectomy was the only treatment proposed for splenic trauma until the 1960s. In 1968, Upadhyaya and Simpson proposed Non-Operative Management (NOM) in a study on 52 pediatric patients with splenic trauma .
The ultimate goal of NOM is to preserve the spleen and it is based on specific principles and criteria. NOM procedures include conservative medical treatment and angioembolization (AE) without access to the peritoneal cavity. Advantages of NOM for minor splenic trauma (grades I and II according to the American Association for the Surgery of Trauma-AAST), have been extensively reported, whereas its value for severe splenic injuries (AAST grades IV and V) is still under debate [2–4]. The aim of this systematic review was to evaluate the available published evidence on NOM in patients with splenic trauma and to compare it with operative management (OM) in terms of mortality, morbidity and duration of hospital stay.
The criteria of the "Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement" were followed in this systematic review .
We analyzed randomized controlled trials (RCTs) and non-randomized controlled studies (non-RCSs) comparing NOM vs. OM for blunt splenic trauma (BST). Only studies with at least 10 patients with BST were included. No language restrictions were imposed.
Studies were excluded if they involved only penetrating splenic trauma or if respective numbers of penetrating and blunt trauma were not specified.
Participants were patients of all ages and either gender who had BST.
Type of intervention
The intervention types were NOM (clinical observation, medical treatment and proximal or distal splenic angioembolization) vs. OM (total or partial splenectomy, splenorrhaphy, application of hemostatic agents).
Sources of information
The following shows the systematic search performed on PubMed for papers published from January 2000 to December 2011:
non[All Fields] AND operative[All Fields] AND ("therapy"[Subheading] OR "therapy"[All Fields] OR "treatment"[All Fields] OR "therapeutics"[MeSH Terms] OR "therapeutics"[All Fields]) AND ("spleen"[MeSH Terms] OR "spleen"[All Fields] OR "splenic"[All Fields])
non[All Fields] AND operative[All Fields] AND ("organization and administration"[MeSH Terms] OR ("organization"[All Fields] AND "administration"[All Fields]) OR "organization and administration"[All Fields] OR "management"[All Fields] OR "disease management"[MeSH Terms] OR ("disease"[All Fields] AND "management"[All Fields]) OR "disease management"[All Fields]) AND ("spleen"[MeSH Terms] OR "spleen"[All Fields] OR "splenic"[All Fields]).
Collection of data
We developed a data collection sheet, including names of authors, type of study, number of patients, type of treatment (NOM vs. OM) and the number of patients per treatment arm, mean age, Injury Severity Score (ISS), blood pressure, gender, American Association for the Surgery of Trauma (AAST) grade of splenic injury. Two authors (RC, ST) extracted data from included studies according to the data collection sheet, while another author (CB) oversaw the process. Controversies were solved by involving a fourth author (GN).
Outcomes of interest
The primary endpoint of this systematic review was considered the overall mortality defined as any death that occurred after the start of NOM or OM and during the hospital stay.
Secondary endpoints were overall morbidity, overwhelming post-splenectomy infection (OPSI)/quality of life, blood transfusion, abdominal abscesses and length of hospital stay.
Two authors performed the statistical analysis according to the PRISMA and the "Cochrane Handbook for Systematic Reviews" guidelines. Odds ratios (OR), (that is, the possibility that an event occurs in the two groups of treatment) were calculated for dichotomous outcomes while a weighted mean difference (WMD) was calculated to summarize the continuous outcomes. The Mantel-Haenszel method was used to combine OR for outcomes of interest. We also verified homogeneity among the studies by calculating the Chi² and the inconsistency (I²). As I² detected absence of homogeneity (>50%), the fixed effect model could not be used, and we, therefore, used the random effect model for analysis. Statistical analysis was conducted using the statistical software Review Manager Version 5.0 (The Nordic Cochrane Centre, The Cochrane Collaboration, 2008, Copenhagen, Denmark).
Five hundred ninety-four studies were identified from our literature search. After review of titles and abstracts, 12 studies were excluded because of overlapping data and 495 because they were not relevant to the aims of our review. We analyzed the full texts of the 87 remaining studies, 21 of them met the inclusion criteria, while 66 were excluded (Figure 1).
Search strategy results
We analyzed 21 non-randomized studies [1, 6–25]: one clinical controlled trial and 20 retrospective cohort studies analyzing a total of 16,940 patients with blunt splenic injury (BSI); 12,449 underwent NOM vs. 4,491 OM (Additional file 1: Table S1).
Quality of included studies
Quality of included studies was assessed by two authors (CR and ST) using the Newcastle-Ottawa Scale (NOS)  and is reported in Additional file 2: Table S2. All included studies had good methodological quality (>5 points) (mean 7.9 points, range 7 to 9).
Risk of bias
Twenty studies [1, 6–14, 16–25] reported participants' age: mean value was specified in 17 studies [1, 6–10, 12, 14, 16–25], the age range in one study  and median age in another study . Crawford et al. reported the age of the 36 patients in whom treatment failed . Mean age was 8.5 ± 5.2 years in the OM group and 9.2 ± 13 years in the NOM group in the study by Jim et al.  and 70.4 ± 9.3 in the group studied by Siriratsivawong et al. . Only two studies [6, 16] enrolled elderly patients, while in the other studies (patients' age was comprised between less than 1  and 53 years ) (Additional file 3: Table S3).
Distribution of ages was not homogeneous, so it was not possible to compare studies according to this parameter.
Only four studies [8, 10, 18, 21] reported hemodynamic characteristics of patients: Duchesne et al. and Dent et al. [8, 18] defined patients as hemodynamically stable (HDS) if blood pressure was >100 mmHg. Scappellato et al. and Wahl et al. [10, 21] treated HDS patients with NOM and hemodynamically unstable patients with OM. Blood pressure values were reported only in 10 studies [9–11, 13, 17, 18, 20–22, 24], seven studies [9, 10, 16, 18, 20, 22, 24] reported the median systolic blood pressure, two studies [11, 13] reported the number of patients with blood pressure above or below 90 mmHg and one study  reported the mean systolic/diastolic blood pressure. One study did not specify blood pressure criteria for NOM or OM . Two studies [11, 13] used the 90 mmHg cut-off without specifying how many patients had blood pressure between 90 and 100 mmHg; therefore, even hemodynamic unstable patients underwent NOM (Additional file 3: Table S3).
Injury Severity Score (ISS)
ISS was reported in 19 studies: mean value was reported in 3 studies [8, 12, 19], median value ± SD in 14 studies [1, 6, 7, 9, 10, 14, 16–18, 20, 22–25], the range of ISS was reported in 1 study , while in another study  ISS was defined with values above or below a cut-off of 25. It was possible to extrapolate the ISS value for the patients in the two compared groups (NOM vs. OM) from only one study , while Costa et al. , Claridge et al. , Gaarder et al.  and Harbrecht et al.  did not differentiate ISS values between NOM or OM. Cochran et al.  and Tsugawa et al.  defined ISS for pediatric or adult patients and for older patients, nevertheless without distinguishing between NOM and OM (Additional file 3: Table S3).
AAST grades of splenic lesions were reported in 11 studies: the number of patients relative to each AAST was reported in 6 studies [14, 18, 20–22], the mean AAST of NOM and OM groups were reported in 5 studies [6, 10, 16, 23, 24], and percentage of patients relative to AAST was reported in 1 study  (Additional file 3: Table S3).
Diagnostic protocol for BST
Only three studies [18, 20, 22] reported the mortality relative to the AAST grading of splenic injuries. In particular, the mortality rate in patients with grades I and II of splenic injuries treated with NOM was 0%, but it was not possible to confirm the grading in patients with minor splenic injuries treated with OM since they did never required surgery [18, 20, 22]. The mortality in patients with grade III injuries was reported only by Duchesne et al.  and was similar in the two treatment groups (16% vs. 23% in NOM and OM, respectively). In patients with grades IV and V of splenic injuries the mortality was analyzed and reported in three studies [18, 20, 22]; mortality was lower in OM than in the NOM groups (mean rate 5.4% (45/337) vs. 13.3% (29/534), respectively). Data on the injuries of grade V was available only in the studies by Duchense et al., this was not possible from the studies by Jim et al.  and Velmahos et al. . In fact, Duchesne et al.  distinguished mortality in grades IV and V (mean rate 31.5% vs. 13.7% in NOM and OM for grade IV - 12.5% vs. 66.6% in NOM and OM for grade V, respectively). Gaarder et al.  and Scappellato et al. , on the other hand, did not report the mortality with respect to the grade of lesion nor to treatment. (Additional file 5: Table S5).
Only three studies [10, 18, 22] compared morbidity in the NOM and OM groups; six studies [6, 8, 12, 14, 15, 21] reported data on morbidity but did not distinguish between the two treatment groups. In those three studies [10, 18, 22], it was possible to analyze morbidity according to the classification of Dindo-Clavien (DC) (Additional files 6, 7, 8: Tables S6-S8). Among 78 patients that underwent OM, 7 presented AAST grade III lesions. Of these, three had DC grade IV and four patients had DC grade V complications; in eight patients with AAST grade IV, two had DC grade IV and six had DC grade V complications. Among seven patients with AAST grade V, three had DC grade IV and four had DC grade V complications. Of the 76 patients who underwent NOM, 1 patient presented a AAST grade I lesion and a DC grade IV complication; 3 patients with AAST grade II had DC grade IV complications. Twelve patients had AAST grade III lesions, seven of whom had a DC grade IV while five had DC grade V complications. Among 15 patients with AAST grade IV lesions, 11 had DC grade IV and 4 had DC grade V complications. Among six patients with AAST grade V lesions, four had DC grade IV while two had DC grade V complications.
Overwhelming post-splenectomy infection (OPSI)/quality of life
None of the included studies reported post-operative follow-up. For this reason, it was not possible to calculate the incidence of OPSI or quality of life after the treatment.
Only seven studies [10, 13–15, 18, 19, 24] reported the number of blood transfusions (Additional file 9: Table S9). Only one study  reported the number of patients who received blood transfusions with respect to the type of treatment, specifying the number of patients who received more than one transfusion: 19/31 in the NOM group vs. 14/15 in the OM group.
Only two studies [6, 14] reported the incidence of abdominal abscesses, without specifying the method used for their detection. Furthermore, the authors did not specify in which group (NOM vs. OM) abscesses occurred and in how many cases they were associated with sepsis (Additional file 10: Table S10).
Duration of hospital stay was reported in 11 studies [6, 7, 9, 12–14, 16, 18, 20, 22, 25]. Only four studies [13, 16, 20, 25] distinguished results between the two groups (NOM vs. OM). Claridge et al.  reported a median value ± SD (Additional file 11: Table S11).
The analysis of subgroups according to the DC classification and AAST grading for splenic trauma was possible only in the study by Duchesne et al.  (see Additional files 6 and 12, Tables S6 and S12). Among 76 patients that underwent NOM, 1 patient presented a AAST grade I lesion and was classed DC grade IV; in 2 patients, AAST grade II lesions were associated with DC grade IV complications. Twelve patients had AAST grade III lesions, seven of whom had DC grade IV while five had DC grade V complications. Among 15 patients with AAST grade IV lesions, 11 had DC grade IV and 4 had DC grade V complications. Among six patients with AAST grade V injury, four had DC grade IV and two had DC grade V complications. Among 78 patients that were treated with OM, 7 had AAST grade III injuries. Three of these patients had DC grade IV and four had DC grade V complications. Among eight patients with AAST grade IV lesions, two had DC grade IV and six had DC grade V complications. Among seven patients with AAST grade V, three had DC grade IV and four DC grade V complications. Overall, hospital stay in the NOM group was shorter than in OM, even if some studies reported a longer hospital stay in NOM because of more lasting monitoring and later return to daily activities [12, 15].
In our systematic review, NOM represented the gold standard treatment for AAST grades I and II in 21 non-randomized studies (Additional file 1: Table S1) and was associated with decreased mortality in severe splenic trauma (AAST grades III to V) (4.78% vs. 13.5% in NOM and OM, respectively) (Additional file 5: Table S5) [20, 22]. Mortality in OM group was higher, even if splenic bleeding was not always indicated as the single cause of death. In severe splenic trauma, it was not possible to determine post-treatment morbidity [10, 18, 22]. Furthermore, we could not establish which one of the treatments was more beneficial in terms of other analyzed outcomes (hospital stay and number of blood transfusions), since results either were not comparable among the studies or they were not reported [19, 27–35].
In the past, the gold standard treatment for minor splenic lesions was early splenectomy [36–38], in order to avoid fatal hemorrhage [20, 35, 39]. Gradually, due to wider knowledge of the role and functions of the spleen, more surgeons preferred a conservative approach, either partial splenic salvage or NOM when possible [8, 14, 23, 29, 31, 33, 39–43]. NOM is a complex, multidisciplinary strategy that starts with careful clinical observation and constant strict monitoring by means of repeated laboratory tests and radiological imaging. Modern imaging techniques, such as multi-slice CT and contrast-enhanced ultrasound, have improved the quantitative definition of hemoperitoneum, evaluation of extension of splenic lesions, active bleeding and presence of concurring lesions in polytrauma patients [32, 44–55].
At present, it appears that NOM can also be the first line treatment in some cases of severe splenic trauma (AAST grades III to V) when the decision between NOM and OM depends on careful risk-benefit analysis for each patient [10, 31–33, 56, 57] as well as on the expertise of the surgeon and of the multidisciplinary team of the hospital.
Splenectomy is not exempt from intra-operative and post-operative complications, such as thrombocytosis, post-splenectomy infections, abdominal abscess and OPSI [59–61]. For these reasons, surgeons have preferred avoiding splenectomy. Nevertheless, the main risk of NOM is the possibility of sudden delayed hemorrhage that could be immediately fatal, before emergency surgery can be performed [1, 8–11, 14–17, 20, 22, 24]. In addition, in NOM, the higher amounts of blood transfusion that are often required, thus increasing the risk of blood-borne disease, such as hepatitis [10, 13–15, 18, 24, 62], and the increased risk of not detecting other intra-abdominal lesions [17, 18, 39, 63], have to be considered with respect to OM.
Unfortunately, follow-up was not reported in the studies included in this analysis; therefore, it was not possible to evaluate long-term complications [23, 58, 56]. The role and frequency of repeating imaging in the follow-up of patients treated with conservative treatment are still under debate [32, 44–55]. Radiological imaging is necessary during the initial phases of NOM in order to evaluate eventual bleeding and abscess formation, and later, in order to detect the development of pseudo-aneurysms [18, 32, 44–55].
Clinical observation of the patient at the moment of hospitalization and monitoring of clinical conditions represent Ariadne's thread that brings caretakers through the labyrinth of laboratory and investigational tests and finally to success (or failure) of NOM [64–69].
In conclusion, NOM has been accepted as standard treatment for AAST grades I and II BST, whereas this was not found to be safe in higher grades of splenic trauma. Currently, there is no consensus in the management of severe splenic trauma. Velmahos, a distinguished trauma surgeon , stated that "generalization about the overall success rates of NOM, should not represent severe blunt splenic injury".
Unfortunately, this review does not clarify the controversies regarding the safest therapeutic approach to severe splenic trauma (AAST grades IV and V) because of the selection bias in the recruitment of the NOM and OM groups, as well as missing data and heterogeneity of the studies included. Furthermore, all studies included in our review were retrospective and none were randomized due to the obvious difficulties in designing a randomized study on NOM of trauma patients.
Given the substantial heterogeneity between levels of expertise in the different hospitals, inclusion of patients with concurrent injuries of other organs and potentially inappropriate comparison groups the conclusions of the review may not be reliable for severe splenic trauma (AAST grades IV and V).
NOM has been accepted as standard treatment for splenic trauma grades I and II.
Advantages of NOM for the more severe splenic injuries are still debated.
This review does not clarify the controversies regarding the safest treatment approach for severe splenic trauma because of the selection bias in the recruitment of the NOM and OM groups, as well as missing data and heterogeneity of the studies included.
NOM can also be the initial treatment in some cases of severe splenic trauma when the decision between NOM and OM depends on careful risk-benefit analysis for each patient as well as on the expertise of the surgeon and of the multidisciplinary team of the hospital.
The definition of hemodynamic stability varied greatly in the literature.
American Association for the Surgery of Trauma
Advanced Life Trauma Support
blunt splenic injury
blunt splenic trauma
clinical control trial
the classification of Dindo-Clavien HDS: hemodynamically stable
Injury Severity Score
overwhelming post splenectomy infection
Preferred Reporting Items for Systematic Reviews and Meta-analyses statement
randomized control studies
randomized control trials
Costa G, Tierno SM, Tomassini F, Venturini L, Frezza B, Cancrini G, Stella F: The epidemiology and clinical evaluation of abdominal trauma. An analysis of a multidisciplinary trauma registry. Ann Ital Chir 2010, 81: 95-102.
Buccoliero F, Ruscelli P: Trauma splenico. In La gestione del trauma. Dal territorio al Trauma Center. Edited by: Cenammo A. Napoli: Società Italiana di Chirurgia; 2010:138-150.
Sanders MN, Civil I: Adult splenic injuries: treatment patterns and predictive indicators. Aust NZ J Surg 1999, 69: 430-432. 10.1046/j.1440-1622.1999.01594.x
Upadhyaya P: Conservative management of splenic trauma: history and current trends. Pediatr Surg Int 2003, 19: 617-627. 10.1007/s00383-003-0972-y
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6: e1000097. 10.1371/journal.pmed.1000097
Tsugawa K, Koyanagi N, Hashizume M, Ayukawa K, Wada H, Tomikawai M, Sugimachi K: New insight for management of blunt splenic trauma: significant differences between young and elderly. Hepatogastroenterology 2002, 49: 1144-1149.
Cochran A, Mann NC, Dean JM, Cook LJ, Barton RG: Resource utilization and its management in splenic trauma. Am J Surg 2004, 187: 713-719. 10.1016/j.amjsurg.2003.10.021
Dent D, Alsabrook G, Erickson BA, Myers J, Wholey M, Stewart R, Root H, Ferral H, Postoak D, Napier D, Pruitt BA Jr: Blunt splenic injuries: high nonoperative management rate can be achieved with selective embolization. J Trauma 2004, 56: 1063-1067. 10.1097/01.TA.0000123037.66867.F2
Harbrecht BG, Zenati MS, Ochoa JB, Townsend RN, Puyana JC, Wilson MA, Peitzman AB: Management of adult blunt splenic injuries: comparison between level I and level II trauma centers. J Am Coll Surg 2004, 198: 232-239. 10.1016/j.jamcollsurg.2003.10.007
Wahl WL, Ahrns KS, Chen S, Hemmila MR, Rowe SA, Arbabi S: Blunt splenic injury: operation versus angiographic embolization. Surgery 2004, 136: 891-899. 10.1016/j.surg.2004.06.026
McIntyre LK, Schiff M, Jurkovich GJ: Failure of nonoperative management of splenic injuries: causes and consequences. Arch Surg 2005, 140: 563-568. discussion 568-569 10.1001/archsurg.140.6.563
Mooney DP, Rothstein DH, Forbes PW: Variation in the management of pediatric splenic injuries in the United States. J Trauma 2006, 61: 330-333. 10.1097/01.ta.0000226167.44892.1d
Cadeddu M, Garnett A, Al-Anezi K, Farrokhyar F: Management of spleen injuries in the adult trauma population: a ten-year experience. Can J Surg 2006, 49: 386-390.
Gaarder C, Dormagen JB, Eken T, Skaga NO, Klow NE, Pillgram-Larsen J, Buanes T, Naess PA: Nonoperative management of splenic injuries: improved results with angioembolization. J Trauma 2006, 61: 192-198. 10.1097/01.ta.0000223466.62589.d9
Crawford RS, Tabbara M, Sheridan R, Spaniolas K, Velmahos GC: Early discharge after nonoperative management for splenic injuries: increased patient risk caused by late failure? Surgery 2007, 142: 337-342. 10.1016/j.surg.2007.05.003
Siriratsivawong K, Zenati M, Watson GA, Harbrecht BG: Nonoperative management of blunt splenic trauma in the elderly: does age play a role? Am Surg 2007, 73: 585-589.
Harbrecht BG, Ko SH, Watson GA, Forsythe RM, Rosengart MR, Peitzman AB: Angiography for blunt splenic trauma does not improve the success rate of nonoperative management. J Trauma 2007, 63: 44-49. 10.1097/TA.0b013e3180686531
Duchesne JC, Simmons JD, Schmieg RE Jr, McSwain NE Jr, Bellows CF: Proximal splenic angioembolization does not improve outcomes in treating blunt splenic injuries compared with splenectomy: a cohort analysis. J Trauma 2008, 65: 1346-1351. 10.1097/TA.0b013e31818c29ea
Bowman SM, Zimmerman FJ, Christakis DA, Sharar SR: The role of hospital profit status in pediatric spleen injury management. Med Care 2008, 46: 331-338. 10.1097/MLR.0b013e318160b492
Jim J, Leonardi MJ, Cryer HG, Hiatt JR, Shew S, Cohen M, Tillou A: Management of high-grade splenic injury in children. Am Surg 2008, 74: 988-992.
Scapellato S, Sciuto G, Maria S, Terranova LE, Castorina G: Blunt splenic injury: authors' experience and comparison to literature. Minerva Chir 2009, 64: 407-414.
Velmahos GC, Zacharias N, Emhoff TA, Feeney JM, Hurst JM, Crookes BA, Harrington DT, Gregg SC, Brotman S, Burke PA, Davis KA, Gupta R, Winchell RJ, Desjardins S, Alouidor R, Gross RI, Rosenblatt MS, Schulz JT, Chang Y: Management of the most severely injured spleen: a multicenter study of the Research Consortium of New England Centers for Trauma (ReCONECT). Arch Surg 2010, 145: 456-460. 10.1001/archsurg.2010.58
Malhotra AK, Carter RF, Lebman DA, Carter DS, Riaz OJ, Aboutanos MB, Duane TM, Ivatury RR: Preservation of splenic immunocompetence after splenic artery angioembolization for blunt splenic injury. J Trauma 2010, 69: 1126-1130. 10.1097/TA.0b013e3181f9fa1e
Bruce PJ, Helmer SD, Harrison PB, Sirico T, Haan JM: Nonsurgical management of blunt splenic injury: is it cost effective? Am J Surg 2011, 202: 810-815. 10.1016/j.amjsurg.2011.06.041
Claridge JA, Carter JW, McCoy AM, Malangoni MA: In-house direct supervision by an attending is associated with differences in the care of patients with a blunt splenic injury. Surgery 2011, 150: 718-726. 10.1016/j.surg.2011.07.078
Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses.Ottawa, ON: Ottawa Hospital Research Institute; [http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm]
Patient Care Committee of the Society for Surgery of the Alimentary Tract (SSAT): Surgical treatment of injuries and diseases of the spleen. J Gastrointest Surg 2005, 9: 453-454.
Thompson BE, Munera F, Cohn SM, MacLean AA, Cameron J, Rivas L, Bajayo D: Novel computed tomography scan scoring system predicts the need for intervention after splenic injury. J Trauma 2006, 60: 1083-1086. 10.1097/01.ta.0000218251.67141.ef
Franklin GA, Casós SR: Current advances in the surgical approach to abdominal trauma. Injury 2006, 37: 1143-1156. 10.1016/j.injury.2006.07.018
Carobbi A, Romagnani F, Antonelli G, Bianchini M: Laparoscopic splenectomy for severe blunt trauma: initial experience of ten consecutive cases with a fast hemostatic technique. Surg Endosc 2010, 24: 1325-1330. 10.1007/s00464-009-0768-9
Fu CY, Wu SC, Chen RJ, Chen YF, Wang YC, Huang HC, Huang JC, Lu CW, Lin WC: Evaluation of need for operative intervention in blunt splenic injury: intraperitoneal contrast extravasation has an increased probability of requiring operative intervention. World J Surg 2010, 34: 2745-2751. 10.1007/s00268-010-0723-x
Buccoliero F, Ruscelli P: Current trends in polytrauma management. Diagnostic and therapeutic algorithms operational in the Trauma Center of Cesena, Italy. Ann Ital Chir 2010, 81: 81-93.
St Peter SD, Sharp SW, Snyder CL, Sharp RJ, Andrews WS, Murphy JP, Islam S, Holcomb GW, Ostlie DJ: Prospective validation of an abbreviated bedrest protocol in the management of blunt spleen and liver injury in children. J Pediatr Surg 2011, 46: 173-177. 10.1016/j.jpedsurg.2010.09.079
Hamlat CA, Arbabi S, Koepsell TD, Maier RV, Jurkovich GJ, Rivara FP: National variation in outcomes and costs for splenic injury and the impact of trauma systems: a population-based cohort study. Ann Surg 2012, 255: 165-170. 10.1097/SLA.0b013e31823840ca
Clancy AA, Tiruta C, Ashman D, Ball CG, Kirkpatrick AW: The song remains the same although the instruments are changing: complications following selective non-operative management of blunt spleen trauma: a retrospective review of patients at a level I trauma centre from 1996 to 2007. J Trauma Manag Outcomes 2012, 6: 4. 10.1186/1752-2897-6-4
Shackford SR, Molin MR: Management of splenic injuries. Surg Clin North Am 1990, 70: 595-620.
Lucas CE: Splenic trauma. Choice of management. Ann Surg 1991, 213: 98-112. 10.1097/00000658-199102000-00002
Pachter HL, Guth AA, Hofstetter SR, Spencer FC: Changing patterns in the management of splenic trauma. Ann Surg 1998, 227: 708-719. 10.1097/00000658-199805000-00011
Yanar H, Ertekin C, Taviloglu K, Kabay B, Bakkaloglu H, Guloglu R: Nonoperative treatment of multiple intra-abdominal solid organ injury after blunt abdominal trauma. J Trauma 2008, 64: 943-948. 10.1097/TA.0b013e3180342023
Williams MD, Young DH, Schiller WR: Trend toward nonoperative management of splenic injuries. Am J Surg 1990, 160: 588-592. discussion 592-593 10.1016/S0002-9610(05)80751-2
Resende V, Petroianu A: Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am J Surg 2003, 185: 311-315. 10.1016/S0002-9610(02)01407-1
Nakae H, Shimazu T, Miyauchi H, Morozumi J, Ohta S, Yamaguchi Y, Kishikawa M, Ueyama M, Kitano M, Ikeuchi H, Yukioka T, Sugimoto H: Does splenic preservation treatment (embolization, splenorrhaphy, and partial splenectomy) improve immunologic function and long-term prognosis after splenic injury? J Trauma 2009, 67: 557-563. 10.1097/TA.0b013e3181af6ca9
Skattum J, Naess PA, Gaarder C: Non-operative management and immune function after splenic injury. Br J Surg 2012,99(Suppl 1):59-65.
Bragg S: Grade IV splenic laceration. J Emerg Nurs 2005, 31: 380. 10.1016/j.jen.2005.04.009
Thompson BE, Munera F, Cohn SM, MacLean AA, Cameron J, Rivas L, Bajayo D: Novel computed tomography scan scoring system predicts the need for intervention after splenic injury. J Trauma 2006, 60: 1083-1086. 10.1097/01.ta.0000218251.67141.ef
Valentino M, Serra C, Zironi G, De Luca C, Pavlica P, Barozzi L: Blunt abdominal trauma: emergency contrast-enhanced sonography for detection of solid organ injuries. AJR Am J Roentgenol 2006, 186: 1361-1367. 10.2214/AJR.05.0027
Koo M, Sabaté A, Magalló P, García MA, Domínguez J, de Lama ME, López S: [Multidisciplinary protocol for computed tomography imaging and angiographic embolization of splenic injury due to trauma: assessment of pre-protocol and post-protocol outcomes]. Rev Esp Anestesiol Reanim 2011, 58: 538-542.
Fick AE, Raychaudhuri P, Bear J, Roy G, Balogh Z, Kumar R: Factors predicting the need for splenectomy in children with blunt splenic trauma. ANZ J Surg 2011, 81: 717-719. 10.1111/j.1445-2197.2010.05591.x
Wurmb TE, Frühwald P, Hopfner W, Keil T, Kredel M, Brederlau J, Roewer N, Kuhnigk H: Whole-body multislice computed tomography as the first line diagnostic tool in patients with multiple injuries: the focus on time. J Trauma 2009, 66: 658-665. 10.1097/TA.0b013e31817de3f4
Wurmb TE, Quaisser C, Balling H, Kredel M, Muellenbach R, Kenn W, Roewer N, Brederlau J: Whole-body multislice computed tomography (MSCT) improves trauma care in patients requiring surgery after multiple trauma. Emerg Med J 2011, 28: 300-304. 10.1136/emj.2009.082164
Hessmann MH, Hofmann A, Kreitner KF, Lott C, Rommens PM: The benefit of multislice CT in the emergency room management of polytraumatized patients. Acta Chir Belg 2006, 106: 500-507.
Clevert D-A, Weckbach S, Minaifar N, Clevert D-A, Stickel M, Reiser M: Contrast-enhanced ultrasound versus MS-CT in blunt abdominal trauma. Clin Hemorheol Microcirc 2008, 39: 155-169.
Kuo WY, Lin HJ, Foo NP, Guo HR, Jen CC, Chen KT: Will computed tomography (CT) miss something? The characteristics and pitfalls of torso CT in evaluating patients with blunt solid organ trauma. Ulus Travma Acil Cerrahi Derg 2011, 17: 215-219. 10.5505/tjtes.2011.12844
Afaq A, Harvey C, Aldin Z, Leen E, Cosgrove D: Contrast-enhanced ultrasound in abdominal trauma. Eur J Emerg Med 2012, 19: 140-145. 10.1097/MEJ.0b013e328348c980
Zarzaur BL, Croce MA, Fabian TC: Variation in the use of urgent splenectomy after blunt splenic injury in adults. J Trauma 2011, 71: 1333-1339. 10.1097/TA.0b013e318224d0e4
Rodeghiero F, Ruggeri M: Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol 2012, 158: 16-29. 10.1111/j.1365-2141.2012.09146.x
Coignard-Biehler H, Lanternier F, Hot A, Salmon D, Berger A, de Montalembert M, Suarez F, Launay O, Lecuit M, Lortholary O: Adherence to preventive measures after splenectomy in the hospital setting and in the community. J Infect Public Health 2011, 4: 187-194. 10.1016/j.jiph.2011.06.004
Okabayashi T, Hanzaki K: Overwhelming post-splenectomy infection syndrome in adults - a clinically preventable disease. World J Gastroenterol 2008, 14: 176-179. 10.3748/wjg.14.176
Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, Woolley I, Spelman D: Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One 2011, 6: e23164. 10.1371/journal.pone.0023164
De Porto AP, Lammers AJ, Bennink RJ, ten Berge IJ, Speelman P, Hoekstra JB: Assessment of splenic function. Eur J Clin Microbiol Infect Dis 2010, 29: 1465-1473. 10.1007/s10096-010-1049-1
Jones P, Leder K, Woolley I, Cameron P, Cheng A, Spelman D: Postsplenectomy infection-strategies for prevention in general practice. Aust Fam Physician 2010, 39: 383-386.
Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG, Billiar TR, Peitzman AB, Moore EE, Cohen MJ, Sperry JL: Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way. J Trauma Acute Care Surg 2012, 72: 892-898.
Hom J: The risk of intra-abdominal injuries in pediatric patients with stable blunt abdominal trauma and negative abdominal computed tomography. Acad Emerg Med 2010, 17: 469-475.
Smith JS Jr, Cooney RN, Mucha P Jr: Nonoperative management of ruptured spleen: a revalidation of criteria. Surgery 1996, 120: 745-750. 10.1016/S0039-6060(96)80026-2
Di Saverio S, Moore EE, Tugnoli G, Naidoo N, Ansaloni L, Bonilauri S, Cucchi M, Catena F: Non operative management of liver and spleen traumatic injuries: a giant with clay feet. World J Emerg Surg 2012, 7: 3. 10.1186/1749-7922-7-3
Peitzman AB, Ferrada P, Puyana JC: Nonoperative management of blunt abdominal trauma: have we gone too far? Surg Infect (Larchmt) 2009, 10: 427-433. 10.1089/sur.2009.021
Todd SR, Arthur M, Newgard C, Hedges JR, Mullins RJ: Hospital factors associated with splenectomy for splenic injury: a national perspective. J Trauma 2004, 57: 1065-1071. 10.1097/01.TA.0000103988.66443.0E
Cagini L, Vannucci J, Scialpi M F: Diagnosis and endovascular treatment of an internal mammary artery injury. J Emerg Med 2013, 44: e117-e119. 10.1016/j.jemermed.2012.02.035
Cagini L, Boaron M, Corneli G, Gambale G, Cirocchi R, Giustozzi G, Spangaro M: Rupture of the azygos vein in blunt chest trauma. J Cardiovasc Surg 1998, 39: 249-250.
We thank Augusto Altavilla who contributed to acquisition and analysis of data.
The authors declare that they have no competing interests.
All authors contributed equally to this work. In particular, RC conceived of the study. RC, CB, CL, AC, EF, ST, CR, JD, AS, LC, AP, AR, GN and AF participated in the original design. RC and ST extracted data from included studies according to the data extraction sheet, while CB oversaw the process. RC and EF analysed the data. RC and AF drafted the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: . Characteristics of included studies. (DOCX 18 KB)
Additional file 2: . Quality of included studied evaluated using the Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. (DOCX 15 KB)
Additional file 3: . Patient characteristic in included studies. (DOCX 24 KB)
Additional file 4: . Diagnostic protocol for blunt splenic trauma (BST). (DOCX 16 KB)
Additional file 5: . Mortality of patients with respect to AAST grade of splenic lesion. (DOCX 12 KB)
Additional file 6: . Classification of morbidity according to Dindo-Clavien: NOM vs OM. (DOCX 18 KB)
Additional file 7: . Morbidity according to Dindo-Clavien classification: NOM vs OM. (DOCX 13 KB)
Additional file 8: . Morbidity according to Dindo-Clavien classification for AAST in NOM vs OM. (DOCX 13 KB)
Additional file 9: . Blood transfusions for different treatments (NOM vs OM). (DOCX 12 KB)
Additional file 10: . Abdominal abscesses in patients treated with NOM vs OM. (DOCX 13 KB)
Additional file 11: . Hospital stay after blunt splenic trauma: NOM vs OM. (DOCX 17 KB)
Additional file 12: . Morbidity according to Dindo-Clavien in blunt splenic trauma: NOM vs OM. (DOCX 17 KB)
About this article
Cite this article
Cirocchi, R., Boselli, C., Corsi, A. et al. Is non-operative management safe and effective for all splenic blunt trauma? A systematic review. Crit Care 17, R185 (2013). https://doi.org/10.1186/cc12868
- Operative Management
- Injury Severity Score
- Blunt Trauma
- Grade Versus
- Splenic Injury